Australia markets open in 7 hours 30 minutes

Castle Biosciences, Inc. (CSTL)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
36.81+0.53 (+1.48%)
As of 10:30AM EST. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
No. of analysts7477
Avg. Estimate-0.47-0.51-1.46-1.52
Low estimate-0.52-0.61-1.51-2.44
High estimate-0.39-0.39-1.38-0.66
Year ago EPS-0.23-0.17-0.54-1.46
Revenue estimateCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
No. of analysts7477
Avg. Estimate23.73M24.62M92.78M113.51M
Low estimate21.9M23.97M91M104M
High estimate25M25.5M94M121.1M
Year ago sales17.3M16.72M62.65M92.78M
Sales growth (year/est)37.20%47.20%48.10%22.30%
Earnings history30/12/202030/03/202129/06/202129/09/2021
Est. EPS-0.12-0.23-0.37-0.4
Actual EPS-0.23-0.17-0.35-0.47
Difference-0.110.060.02-0.07
Surprise %-91.70%26.10%5.40%-17.50%
EPS trendCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
Current estimate-0.47-0.51-1.46-1.52
7 days ago-0.47-0.51-1.46-1.52
30 days ago-0.49-0.51-1.47-1.5
60 days ago-0.48-0.51-1.47-1.45
90 days ago-0.39-0.41-1.35-1.11
EPS revisionsCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
Up last 7 days1N/A1N/A
Up last 30 days2N/A21
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/A1N/A1
Growth estimatesCSTLIndustrySector(s)S&P 500
Current qtr.-104.30%N/AN/AN/A
Next qtr.-200.00%N/AN/AN/A
Current year-170.40%N/AN/AN/A
Next year-4.10%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A